Integrated BioPharma, Inc.

Integrated BioPharma, Inc. financial statements

Integrated BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 43.87M10-K
Net income−USD 2.84M10-K
Cash and equivalentsUSD 4.47M10-Q

Integrated BioPharma, Inc. financials on 6ix · Integrated BioPharma, Inc. on 6ix